Bellevue Asset Management (Switzerland)’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q4	$6.81M	Hold	65,000	–	–	1.04%	31
2015 Q3	$6.85M	Hold	65,000	–	–	1.12%	29
2015 Q2	$8.89M	Sell	65,000 -36,000	-36%	-$4.92M	1.23%	27
2015 Q1	$11.4M	Buy	+101,000	New	+$11.4M	1.58%	15